Product NDC: | 65862-526 |
Proprietary Name: | Pioglitazone Hydrochloride and Metformin Hydrochloride |
Non Proprietary Name: | Pioglitazone Hydrochloride and Metformin Hydrochloride |
Active Ingredient(s): | 850; 15 mg/1; mg/1 & nbsp; Pioglitazone Hydrochloride and Metformin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-526 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200823 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130213 |
Package NDC: | 65862-526-18 |
Package Description: | 180 TABLET, FILM COATED in 1 BOTTLE (65862-526-18) |
NDC Code | 65862-526-18 |
Proprietary Name | Pioglitazone Hydrochloride and Metformin Hydrochloride |
Package Description | 180 TABLET, FILM COATED in 1 BOTTLE (65862-526-18) |
Product NDC | 65862-526 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pioglitazone Hydrochloride and Metformin Hydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20130213 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE |
Strength Number | 850; 15 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |